These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 26960162)
1. GM1 ganglioside reverses the cognitive deficits induced by MK801 in mice. Ni YF; Zhang W; Bao XF; Wang W; Song L; Jiang B Behav Pharmacol; 2016 Aug; 27(5):451-9. PubMed ID: 26960162 [TBL] [Abstract][Full Text] [Related]
2. Small-molecule TrkB agonist 7,8-dihydroxyflavone reverses cognitive and synaptic plasticity deficits in a rat model of schizophrenia. Yang YJ; Li YK; Wang W; Wan JG; Yu B; Wang MZ; Hu B Pharmacol Biochem Behav; 2014 Jul; 122():30-6. PubMed ID: 24662915 [TBL] [Abstract][Full Text] [Related]
3. A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats. Manahan-Vaughan D; von Haebler D; Winter C; Juckel G; Heinemann U Hippocampus; 2008; 18(2):125-34. PubMed ID: 17924525 [TBL] [Abstract][Full Text] [Related]
4. [Blockade of NMDA receptor enhances corticosterone-induced downregulation of brain-derived neurotrophic factor gene expression in the rat hippocampus through cAMP response element binding protein pathway]. Feng H; Lu LM; Huang Y; Zhu YC; Yao T Sheng Li Xue Bao; 2005 Oct; 57(5):537-44. PubMed ID: 16220190 [TBL] [Abstract][Full Text] [Related]
5. Voluntary wheel running ameliorates symptoms of MK-801-induced schizophrenia in mice. Kim TW; Kang HS; Park JK; Lee SJ; Baek SB; Kim CJ Mol Med Rep; 2014 Dec; 10(6):2924-30. PubMed ID: 25323073 [TBL] [Abstract][Full Text] [Related]
6. ω-3PUFAs Improve Cognitive Impairments Through Ser133 Phosphorylation of CREB Upregulating BDNF/TrkB Signal in Schizophrenia. Guo C; Liu Y; Fang MS; Li Y; Li W; Mahaman YAR; Zeng K; Xia Y; Ke D; Liu R; Wang JZ; Shen H; Shu X; Wang X Neurotherapeutics; 2020 Jul; 17(3):1271-1286. PubMed ID: 32367475 [TBL] [Abstract][Full Text] [Related]
7. Sustained NMDA receptor hypofunction impairs brain-derived neurotropic factor signalling in the PFC, but not in the hippocampus, and disturbs PFC-dependent cognition in mice. Tanqueiro SR; Mouro FM; Ferreira CB; Freitas CF; Fonseca-Gomes J; Simões do Couto F; Sebastião AM; Dawson N; Diógenes MJ J Psychopharmacol; 2021 Jun; 35(6):730-743. PubMed ID: 34008450 [TBL] [Abstract][Full Text] [Related]
8. Risperidone ameliorates cognitive deficits, promotes hippocampal proliferation, and enhances Notch signaling in a murine model of schizophrenia. Xue F; Chen YC; Zhou CH; Wang Y; Cai M; Yan WJ; Wu R; Wang HN; Peng ZW Pharmacol Biochem Behav; 2017 Dec; 163():101-109. PubMed ID: 29037878 [TBL] [Abstract][Full Text] [Related]
9. Sigma-1 receptor in brain ischemia/reperfusion: Possible role in the NR2A-induced pathway to regulate brain-derived neurotrophic factor. Xu Q; Ji XF; Chi TY; Liu P; Jin G; Chen L; Zou LB J Neurol Sci; 2017 May; 376():166-175. PubMed ID: 28431607 [TBL] [Abstract][Full Text] [Related]
10. Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter-1 (GlyT1). Manahan-Vaughan D; Wildförster V; Thomsen C Eur J Neurosci; 2008 Oct; 28(7):1342-50. PubMed ID: 18973561 [TBL] [Abstract][Full Text] [Related]
11. GM1 Ameliorates Lead-Induced Cognitive Deficits and Brain Damage Through Activating the SIRT1/CREB/BDNF Pathway in the Developing Male Rat Hippocampus. Chen F; Zhou CC; Yang Y; Liu JW; Yan CH Biol Trace Elem Res; 2019 Aug; 190(2):425-436. PubMed ID: 30414004 [TBL] [Abstract][Full Text] [Related]
12. The M₁/M₄ preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia. Barak S; Weiner I Int J Neuropsychopharmacol; 2011 Oct; 14(9):1233-46. PubMed ID: 21211109 [TBL] [Abstract][Full Text] [Related]
13. A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease. Harada K; Nakato K; Yarimizu J; Yamazaki M; Morita M; Takahashi S; Aota M; Saita K; Doihara H; Sato Y; Yamaji T; Ni K; Matsuoka N Eur J Pharmacol; 2012 Jun; 685(1-3):59-69. PubMed ID: 22542656 [TBL] [Abstract][Full Text] [Related]
14. Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseCgamma activity and glutamate receptor expression. Giralt A; Rodrigo T; Martín ED; Gonzalez JR; Milà M; Ceña V; Dierssen M; Canals JM; Alberch J Neuroscience; 2009 Feb; 158(4):1234-50. PubMed ID: 19121372 [TBL] [Abstract][Full Text] [Related]
15. Disruption of calmodulin-dependent protein kinase II α/brain-derived neurotrophic factor (α-CaMKII/BDNF) signalling is associated with zinc deficiency-induced impairments in cognitive and synaptic plasticity. Yu X; Ren T; Yu X Br J Nutr; 2013 Dec; 110(12):2194-200. PubMed ID: 23823484 [TBL] [Abstract][Full Text] [Related]
16. WSKY, a traditional Chinese decoction, rescues cognitive impairment associated with NMDA receptor antagonism by enhancing BDNF/ERK/CREB signaling. Guo X; Chen ZH; Wang HL; Liu ZC; Wang XP; Zhou BH; Yang C; Zhang XP; Xiao L; Shu C; Chen JX; Wang GH Mol Med Rep; 2015 Apr; 11(4):2927-34. PubMed ID: 25503442 [TBL] [Abstract][Full Text] [Related]
17. Subchronic pharmacological and chronic genetic NMDA receptor hypofunction differentially regulate the Akt signaling pathway and Arc expression in juvenile and adult mice. Takagi S; Balu DT; Coyle JT Schizophr Res; 2015 Mar; 162(1-3):216-21. PubMed ID: 25592804 [TBL] [Abstract][Full Text] [Related]
18. NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model. Burnouf S; Martire A; Derisbourg M; Laurent C; Belarbi K; Leboucher A; Fernandez-Gomez FJ; Troquier L; Eddarkaoui S; Grosjean ME; Demeyer D; Muhr-Tailleux A; Buisson A; Sergeant N; Hamdane M; Humez S; Popoli P; Buée L; Blum D Aging Cell; 2013 Feb; 12(1):11-23. PubMed ID: 23082852 [TBL] [Abstract][Full Text] [Related]
19. Long-term behavioral and NMDA receptor effects of young-adult corticosterone treatment in BDNF heterozygous mice. Klug M; Hill RA; Choy KH; Kyrios M; Hannan AJ; van den Buuse M Neurobiol Dis; 2012 Jun; 46(3):722-31. PubMed ID: 22426399 [TBL] [Abstract][Full Text] [Related]
20. Exogenous GM1 Ganglioside Attenuates Ketamine-Induced Neurocognitive Impairment in the Developing Rat Brain. Meng C; Yao XQ; Chang RJ; Wang SL; Wang X; Ma DQ; Li Q; Wang XY Anesth Analg; 2020 Feb; 130(2):505-517. PubMed ID: 31934908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]